Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
3.460
-0.010 (-0.29%)
At close: Oct 9, 2026, 4:00 PM EDT
3.484
+0.024 (0.69%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Wave Life Sciences Stock Forecast
WVE's stock price has decreased by -52.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 19 analysts polled by S&P Global, Wave Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $18.06. The average 1-year stock price forecast is 421.97% higher than the current stock price, while the lowest is $10 (+189.02%) and the highest is $42 (+1,113.87%).
Price Target: $18.06 (+421.97%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 14 | 15 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $42 | Buy | Maintains | $42 | +1,113.87% | Oct 7, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +275.72% | Oct 2, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $17 | Buy | Maintains | $17 | +391.33% | Oct 2, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $10 | Buy | Initiates | $10 | +189.02% | Oct 1, 2026 |
Financial Forecast
Revenue This Year
50.93M
from 42.73M
Increased by 19.21%
Revenue Next Year
35.53M
from 50.93M
Decreased by -30.24%
EPS This Year
-1.10
from -1.21
EPS Next Year
-1.16
from -1.10
EPS and Forward PE are based on non-GAAP adjusted numbers.